Related Experiment Video
Updated: Jul 28, 2026

Protocols for Vaginal Inoculation and Sample Collection in the Experimental Mouse Model of Candida vaginitis
Published on: December 8, 2011
Fever and leukocytosis related to terconazole vaginal suppository
S S Hyder1, J E Manjon, N M Gantz
1Department of Medicine, Polyclinic Medical Center, Harrisburg, PA 17100.
Abstract:
We describe a 22-year-old woman who developed fever, shaking chills, and leukocytosis after insertion of a terconazole (80 mg) vaginal suppository for mild vaginal candidiasis. The patient became afebrile and asymptomatic 24 hours after hospital admission without antibiotic therapy. More experience with terconazole is needed before it can be considered as safe as other imidazole derivatives that have been available for more than 15 years.
Related Concept Videos
Urinary Tract Infection IV: Nursing Management
Cryptococcal Meningitis
Candidiasis
Trichomoniasis
Antifungal Agents
Antiprotozoal Agents

